Join Eyewitness News anchor Liz Cho for our annual, Emmy Award-winning WABC-TV special "Breakthroughs for Breast Cancer" on Sunday, October 13th at 5:30 p.m.

Many patients with brain metastases who experience initial neurocognitive failure (NCF) following brain radiation thera ...

Intensity-modulated radiation therapy (IMRT) and proton beam therapy (PBT) offer similar outcomes for patients with loc ...

In new research, a team led by University of Cincinnati researchers has identified a potential new way to make radiation more ...

Answer: Women diagnosed with breast cancer are almost immediately confronted with treatment decisions. If your surgical ...

A phase 2/3 non-inferiority study compared de-escalation strategies to standard chemoradiation in patients with human ...

Jeffrey Wong, MD, discusses findings on the use of Cu 64 anti-CEA M5A as a PET imaging agent for advanced rectal cancer presented at the 2024 American Society for Radiation Oncology Annual Meeting.

A sizeable proportion of patients with cancer who experience cognitive decline after radiation treatment for brain metastases ...

For patients undergoing breast reconstruction, a 16-fraction course of hypofractionated postmastectomy radiation therapy ...

A radionuclide agent, Lu-177 dotatate was approved by the FDA in 2018 for gastroenteropancreatic neuroendocrine tumors ...

Adding immunotherapy to chemoradiation therapy (CRT) for limited-stage small cell lung cancer (SCLC) failed to improve ...

A new study shows that mastectomy patients can safely receive a shorter course of radiation therapy, reducing treatment time by half without compromising reconstructive surgery. The study involved 650 ...